Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Forging a New Path into the Medical Cannabis Space

Although 2019 was in many ways ‘The Year that the Cannabis Sector Would Like to Forget’, there are many pioneering ways that a company can take to generate revenue in the still-emerging medical cannabis and CBD markets. One such company has been advancing st...
Dave Jackson | February 13, 2020 |

XPhyto: The Cutting Edge of Medical Cannabis Science

At the forefront of the next wave of cannabis commercialization, is a German-focused company with headquarters in Vancouver, XPhyto Therapeutics Corp. (CSE: XPHY; FSE: 4XT) , that is building a much-coveted cannabis R&D cultivation facility in a converted nuclear bunker and o...
Marc Davis | May 14, 2020 |

XPhyto: The Cutting Edge of Medical Cannabis Science

At the forefront of the next wave of cannabis commercialization, is a German-focused company with headquarters in Vancouver, XPhyto Therapeutics Corp. (CSE: XPHY; FSE: 4XT) , that is building a much-coveted cannabis R&D cultivation facility in a converted nuclear bunker and o...
Marc Davis | November 12, 2019 |

Aethlon Medical CEO Jim Joyce Discusses the Forthcoming 'Concussion' Movie and CTE Research Being Co

Aethlon Medical CEO Jim Joyce Discusses the Forthcoming 'Concussion' Movie and CTE Research Being Conducted by Aethlon's Exosome Sciences Subsidiary Source: Gail Dutton of The Life Sciences Report (12/22/15) https://www.thelifesciencesreport.com/pub/na/aethlon-medical...
Gail Dutton | December 23, 2015 |

Nemaura Medical Accelerates Launch of sugarBEAT Wearable Continuous Glucose Monitor

Shares of Nemaura Medical traded 20% higher after the firm reported that it is investigating using its non-invasive continuous glucose monitor sugarBEAT® jointly with its planned health subscription service BEAT®diabetes, to provide personalized lifestyle c...
Streetwise Reports | February 27, 2020 |

Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer ...

Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer Detection and Surgery The disruptive technology is 'poised to deliver significant advancement in bladder cancer detection.' Imagin Medical Inc. (IME:CSE; ...
Streetwise Reports | January 15, 2020 |

Reigniting the Cannabis Oral Delivery System Marketplace

This podcast is part of our Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public marketplace. Stockhouse Media's Dave Jackson was recently joined live with Bra...
Dave Jackson | September 23, 2019 |

Zynex Shares Trade Higher After Reporting a 95% Increase in Q3 Orders

Non-invasive medical device maker Zynex Inc's. shares are trading 12% higher on an overall down market day after the company reported that Q3/19 orders are up 95% over the same period in 2018. This morning medical technology company specializing in manufacturing and s...
Streetwise Reports | October 3, 2019 |

Varian Shares Trade Higher on Yearly Earnings and FY/20 Guidance

Shares of Varian Medical Systems traded 10% higher at times today after the company reported quarterly and annual earnings. The company increased revenue 10% year-over-year and provided FY/20 guidance. Yesterday afternoon medical device maker Varian Medical Systems I...
Streetwise Reports | October 26, 2019 |

Disrupting the Cannabinoid Industry with Science and Innovation

(Click image to play video) Get to know Toronto-based Avicanna Inc. (AVCN) ( TSX.AVCN , OTC: AVCNF , Forum ) – a biopharmaceutical company developing and driving biopharmaceutical advancements of plant-derived cannabinoid-based products, and the man at the h...
Dave Jackson | May 6, 2021 |
1 2 3 4 5 6 7 8 9 10 ...